Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The missed expectations on Mounjaro and Zepbound sales compelled David Risinger of Leerink Partners to lower his firms 12-month price target on Lilly shares but only by 2%, from $990 to $970, though he maintained his firms Outperform rating on the stock
If the prior authorization request is denied, your insurer will typically provide a detailed explanation
Several research studies were conducted on rats where exogenous GHRF (1-29) amide was introduced in conscious and anesthetized rats
Its ethiopathogenesis is unknown
US$ 22.18
US$ 23.84
US$ 21.04
US$ 22.02
